Withdrawal-like behavior in planarians is dependent on drug exposure duration

Neuroscience Letters

Volumn 439, Issue 1, 2008, Pages 84-88

  Sacavage, Steve ^a   Patel, Hiren ^a   Zielinski, Mike ^a   Acker, Jeneane ^a   Phillips, Austin G ^a   Raffa, Robert B ^a   Rawls, Scott M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

Caffeine; Cocaine; Dependence; Methamphetamine; Planarians; Withdrawal

Indexed keywords

CAFFEINE; COCAINE; METHAMPHETAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG DEPENDENCE; DRUG EFFECT; DRUG EXPOSURE; DRUG WITHDRAWAL; EXPERIMENTAL ANIMAL; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; TURBELLARIA;

ANIMALS; BEHAVIOR, ANIMAL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; METHAMPHETAMINE; MOTOR ACTIVITY; PLANARIANS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 44649163824     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.04.086     Document Type: Article

References (47)

1. Agata K., and Watanabe K. Molecular and cellular aspects of planarian regeneration. Semin. Cell Dev. Biol. 10 (1999) 377-383
2. Agata K. The Zoological Society Prize Molecular and cellular approaches to planarian regeneration. Zool. Sci. 19 (2002) 1391-1392
3. Algeri S., Carolei A., Ferretti P., Gallone C., Palladini G., and Venturini G. Effects of dopaminergic agents on monoamine levels and motor behavior in planaria. Comp. Biochem. Physiol. C 74 (1983) 27-29
4. Bhargava H.N. Drugs that modify opioid tolerance, physical dependence, and abstinence symptoms: preclinical and clinical studies. NIDA Res. Monogr. 147 (1995) 53-83
5. Budney A.J., and Hughes J.R. The cannabis withdrawal syndrome. Curr. Opin. Psychiatry 19 (2006) 233-238
6. Burrowes W.R., Assanah P., and Stefano G.B. Behavioral effects of opiates on the land snail Helix aspersa. Life Sci. 33 suppl. 1 (1983) 381-384
7. Carolei A., Margotta V., and Palladini G. Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations. Neuropsychobiology 1 (1975) 355-364
8. Cebria F., Kudome T., Nakazawa M., Mineta K., Ikeo K., Gojobori T., and Agata K. The expression of neural-specific genes reveals the structural and molecular complexity of the planarian central nervous system. Mech. Dev. 116 (2002) 199-204
9. Cebrià F. Regenerating the central nervous system: how easy for planarians!. Dev. Genes Evol. 217 (2007) 733-748
10. Csaba G., and Kádár M. The effect of sympathicomimetic agents on carbohydrate metabolism of planaria. Acta Physiol. Acad. Sci. Hung. 53 (1979) 323-326
11. Eriksson K.S., and Panula P. gamma-Aminobutyric acid in the nervous system of a planarian. J. Comp. Neurol. 345 (1994) 528-536
12. Eshleman A.J., Henningsen R.A., Neve K.A., and Janowsky A. Release of dopamine via the human transporter. Mol. Pharmacol. 45 (1994) 312-316
13. Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., Macgregor R.R., Hitzemann R., Logan J., Bendriem B., and Gatley S.J. Mapping cocaine binding sites in human and baboon brain in vivo. Synapse 4 (1989) 371-377
14. Gawin F.H., and Ellinwood Jr. E.H. Cocaine and other stimulants. Actions, abuse, and treatment. N. Engl. J. Med. 318 (1988) 1173-1182
15. Higgins G.A., Grzelak M.E., Pond A.J., Cohen-Williams M.E., Hodgson R.A., and Varty G.B. The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A2A receptors. Behav. Brain Res. 185 (2007) 32-42
16. Ise Y., Narita M., Nagase H., and Suzuki T. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Psychopharmacology (Berl.) 151 (2000) 49-54
17. Kavaliers M., and Hirst M. Tolerance to the morphine-influenced thermal response in the terrestrial snail Cepea nemoralis. Neuropharmacology 22 (1983) 1321-1326
18. Kavaliers M. Evolutionary and comparative aspects of nociception. Brain Res. Bull. 21 (1988) 923-931
19. Malin D.H., Lake J.R., Carter V.A., Cunningham J.S., and Wilson O.B. Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology (Berl.) 112 (1993) 339-342
20. Newmark P.A., and Sanchez Alvarado A. Not your father's planarian: a classic model enters the era of functional genomics. Nat. Rev. Genet. 3 (2002) 210-219
21. Newmark P.A., Reddien P.W., Cebria F., and Sanchez Alvarado A. Ingestion of bacterially expressed double-stranded RNA inhibits gene expression in planarians. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 11861-11865
22. Newton T.F., De La Garza 2nd R., Kalechstein A.D., and Nestor L. Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacol. Biochem. Behav. 82 (2005) 90-97
23. Palladini G., Margotta V., Carolei A., and Conforti A. Pharmacological, electronmicroscopic and histochemical study on an in vivo model of the dopaminergic nervous system (Dugesia gonocephala s.l). Acta Neurol. (Napoli) 31 (1976) 1-5
24. Palladini G., Ruggeri S., Stocchi F., De Pandis M.F., Venturini G., and Margotta V. A pharmacological study of cocaine activity in planaria. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 115 (1996) 41-45
25. Passarelli F., Merante A., Pontieri F.E., Margotta V., Venturini G., and Palladini G. Opioid-dopamine interaction in planaria: a behavioral study. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol. 124 (1999) 51-55
26. Popik P., and Skolnick P. The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol. Biochem. Behav. 53 (1996) 791-797
27. Raffa R.B., and Valdez J.M. Cocaine withdrawal in Planaria. Eur. J. Pharmacol. 430 (2001) 143-145
28. Raffa R.B., Holland L.J., and Schulingkamp R.J. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. J. Pharmacol. Toxicol. Methods 45 (2001) 223-226
29. Raffa R.B., Stagliano G.W., and Umeda S. kappa-Opioid withdrawal in Planaria. Neurosci. Lett. 349 (2003) 139-142
30. Raffa R.B., Baron D.A., and Tallarida R.J. Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria. Eur. J. Pharmacol. 540 (2006) 200-201
31. Raffa R.B., Cavallo F., and Capasso A. Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists. Eur. J. Pharmacol. 564 (2007) 88-93
32. Raffa R.B., Stagliano G.W., Ross G., Powell J.A., Phillips A.G., Ding Z., and Rawls S.M. The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. Brain Res. 1193 (2008) 51-56
33. Rawls S.M., Gomez T., Ding Z., and Raffa R.B. Differential behavioral effect of the TRPM8/TRPA1 channel agonist icilin (AG-3-5). Eur. J. Pharmacol. 575 (2007) 103-104
34. Rawls S.M., Gomez T., and Raffa R.B. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol. Biochem. Behav. 86 (2007) 499-504
35. Rawls S.M., Gomez T., Stagliano G.W., and Raffa R.B. Measurement of glutamate and aspartate in Planaria. J. Pharmacol. Toxicol. Methods 53 (2006) 291-295
36. Rawls S.M., Rodriguez T., Baron D.A., and Raffa R.B. A nitric oxide synthase inhibitor (l-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria. Brain Res. 1099 (2006) 82-87
37. Solinas M., Ferré S., You Z.B., Karcz-Kubicha M., Popoli P., and Goldberg S.R. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J. Neurosci. 22 (2002) 6321-6324
38. Umeda S., Stagliano G.W., and Raffa R.B. Cocaine and kappa-opioid withdrawal in Planaria blocked by d-, but not l-glucose. Brain Res. 1018 (2004) 181-185
39. Umeda S., Stagliano G.W., Borenstein M.R., and Raffa R.B. A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. J. Pharmacol. Toxicol. Methods 51 (2005) 73-76
40. Venturini G., Carolei A., Palladini G., Margotta V., and Lauro M.G. Radioimmunological and immunocytochemical demonstration of Met-enkephalin in planaria. Comp. Biochem. Physiol. C 74 (1983) 23-25
41. Venturini G., Stocchi F., Margotta V., Ruggieri S., Bravi D., Bellantuono P., and Palladini G. A pharmacological study of dopaminergic receptors in planaria. Neuropharmacology 28 (1989) 1377-1382
42. Volkow N.D., Fowler J.S., Wolf A.P., and Gillespi H. Metabolic studies of drugs of abuse. NIDA Res. Monogr. 105 (1990) 47-53
43. Volkow N.D., Wang G.J., Fischman M.W., Foltin R.W., Fowler J.S., Abumrad N.N., Vitkun S., Logan J., Gatley S.J., Pappas H., Hitzemann R., and Shea C.E. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386 (1997) 827-830
44. Welsh J.H., and Williams W.D. Monoamine-containing neurons in planaria. J. Comp. Neurol. 138 (1970) 103-115
45. Wilmouth C.E., and Spear L.P. Withdrawal from chronic nicotine in adolescent and adult rats. Pharmacol. Biochem. Behav. 85 (2006) 648-657
46. Yoshimura K., and Yamamoto K. Neuropharmacological studies on drug dependence. Effects due to the difference in strain, sex and drug administration time on physical dependence development and characteristics of withdrawal signs in CNS-affecting drug dependent rats. Nippon Yakurigaku Zasshi 75 (1979) 805-828
47. Zabala N.A., and Gómez M.A. Morphine analgesia, tolerance and addiction in the cricket Pteronemobius sp. (Orthoptera Insecta). Pharmacol. Biochem. Behav. 40 (1991) 887-891